Switch View
© BusinessWire
11.09.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 STRIDE-13 trial evaluating CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) at the 6th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Conference on Vaccines, taking place in Lisbon, Portugal. T...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US53635D2027
Liquidia Corp
LQDA
LISTED
NASDAQ
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
News Preview
MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four posters at the Pulmonary Hypertension Professional Association (PHPN) Symposium taking place Septe...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US31573L1052
FibroBiologics Inc.
FBLG
LISTED
NASDAQ
FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment
News Preview
Pilot studies underway to advance IND-enabling preclinical development Pilot studies underway to advance IND-enabling preclinical development...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
11.09.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
News Preview
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP)...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
11.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04 NET ASSET VALUE The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 10 September 2025 was 359.43p (cum income). ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
News Preview
Supports Clinical Development of CLR 121225, Actinium-Labeled Compound for the Treatment of Solid Tumors Supports Clinical Development of CLR 121225, Actinium-Labeled Compound for the Treatment of Solid Tumors...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US00091E1091
Absci Corp
ABSI
LISTED
NASDAQ
Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
News Preview
Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix Announces One-for-Twenty Reverse Stock Split
News Preview
LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) (“Biodesix” or the “Company”), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Monday,...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: CA45074T1021
Ianthus Capital Holdings Inc.
IAN
LISTED
CSE
iAnthus Expands Florida Footprint with GrowHealthy Dispensary Opening in Tamarac
News Preview
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary of Tamarac...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant and support its further adoption. Substantial investment into research to expand access and indications have led to these important results designed to...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US2214133058
Cosmos Health Inc
COSM
LISTED
NASDAQ
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
News Preview
Cosmos Health signs distribution deal with Scientific Pharmacy to launch Sky Premium Life in Oman, including an initial order of 42,000 supplement units....
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces Their Multi Unit Franchisee Has Signed a New Location in South Surrey, British Columbia
News Preview
Toronto, Ontario--(Newsfile Corp. - September 11, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Heal Wellness has secured a real-estate location in South Surrey's Grandview Central. The franchisee is an experienced m...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
11.09.2025
ISIN: US5787841007
Maze Therapeutics Inc
MAZE
LISTED
NASDAQ
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
News Preview
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US5787841007
Maze Therapeutics Inc
MAZE
LISTED
NASDAQ
Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)
News Preview
Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for both intended indications of PKU and CKD...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US03770N1019
Apogee Therapeutics Inc
APGE
LISTED
NASDAQ
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
News Preview
SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced data from the Phase 2 APEX trial of APG777 for m...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation
News Preview
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) will host an Investor Day in New York City today. Senior executives will provide an update on the company’s plans to drive shareholder value creation through its unique business model and capabilities in the large and growing market for funding biopharma innovation wit...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: KYG1281K1067
Silexion Therapeutics Corp
SLXN
LISTED
NASDAQ
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration
News Preview
New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
News Preview
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from its portfolio of next-generation ultra-long acting, scalable, and combinable therapies at the 61st A...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US74365A3095
Protalix Biotherapeutics Inc
PLX
LISTED
XASE
Protalix BioTherapeutics to Present at Investor Summit Virtual
News Preview
CARMIEL, ISRAEL / ACCESS Newswire / September 11, 2025 / Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that Eyal Ru...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
News Preview
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CH1129677105
Medmix AG
MEDX
LISTED
SIX
medmix Announces Strategic Partnership with Gurit for Sustainable Solutions for Industrial Bonding Applications
News Preview
Baar, Switzerland--(Newsfile Corp. - September 11, 2025) - medmix AG Neuhofstrasse 20 CH-6430 Baarcommunications@medmix.com www.medmix.swissMEDIA RELEASEDOWNLOAD MEDIA RELEASEmedmix Announces Strategic Partnership with Gurit for Sustainable Solutions for Industrial Bonding Applications medmix has partnered...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Secures $2.54M Memorabilia Inventory, Reinforcing Growth and Supporting AI Healthcare Mission
News Preview
With high-value assets including a LeBron James 2016 NBA Finals game worn jersey and rare Tom Brady 1/1 card, Infinite Auctions bolsters MDCE's balance sheet to accelerate development of its AI health platform. MESA, ARIZONA / ACCESS Newswire / September 11, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today announced that its subsidiary I...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.09.2025
ISIN: DE000A2P4LJ5
PharmaSGP Holding SE
PSG
LISTED
XETRA
PharmaSGP veröffentlicht vorläufige Halbjahreszahlen 2025
News Preview
PharmaSGP veröffentlicht vorläufige Halbjahreszahlen 2025
Gräfelfing, 11. September 2025 – Das deutsche OTC-Pharmaunternehmen PharmaSGP Holding SE hat im ersten Halbjahr 2025 auf Basis vorläufiger, ungeprüfter Zahlen einen Umsatz von 66,0 Mio. EUR erzielt. Damit konnte der Umsatz gegenüber dem Vorjahr um 13,0 % gesteigert werden (Vorjahr: 58,4 Mi......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.09.2025
ISIN: DE000A2P4LJ5
PharmaSGP Holding SE
PSG
LISTED
XETRA
PharmaSGP publishes preliminary half-year figures for 2025
News Preview
PharmaSGP publishes preliminary half-year figures for 2025
Gräfelfing, September 11, 2025 – The German OTC pharmaceutical company PharmaSGP Holding SE generated revenues of €66.0 million in the first half of 2025 based on preliminary, unaudited figures. This corresponds to a 13.0% increase in revenues compared to the previous year (€58.4 million)......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US45840Y2037
Interactive Strength, Inc.
TRNR
LISTED
NASDAQ
Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ's About Increased Guidance to $80M Pro Forma Revenue, Sportstech and TRNR's $50M Digital Asset Treasury
News Preview
AUSTIN, TX / ACCESS Newswire / September 11, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands and pending acquirer of Sportstech, today announced that it has updated its investor FAQ's on its investor website in re...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: DK0061804697
H Lundbeck A/S
HLUN A
LISTED
CPH
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine
News Preview
Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on eptinezumab (Vypeti®) and Lu AG09222 (anti-PACAP mAb)New data from the open-label extension of the RESOLUTION tr...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
News Preview
The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline LAVAL, QC, AND CUPERTINO, CA / ACCESS Newswire / September 11, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health"), a glo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US6300872032
NanoViricides, Inc.
NNVC
LISTED
XASE
RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
News Preview
This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Wed...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
ENHERTU® Type II Variation Application Validated in the EU for Previously Treated Patients with HER2 Positive Metastatic Solid Tumors
News Preview
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) for the treatment of adult patients with HER2 positive (immunohistochemistry [IHC] 3+) unresectable or metastatic solid tumors who have received prior treatment and have no satisfactory alternative treat...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: DK0061804697
H Lundbeck A/S
HLUN A
LISTED
CPH
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine
News Preview
Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on eptinezumab (Vypeti®) and Lu AG09222 (anti-PACAP mAb)New data from the open-label extension of the RESOLUTION tr...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: DK0061804697
H Lundbeck A/S
HLUN A
LISTED
CPH
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine
News Preview
Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on eptinezumab (Vypeti®) and Lu AG09222 (anti-PACAP mAb)New data from the open-label extension of the RESOLUTION tr...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US74366E1029
Protagonist Therapeutics Inc
PTGX
LISTED
NASDAQ
Protagonist Announces Icotrokinra Application for Approval in Plaque Psoriasis Submitted to the European Medicines Agency
News Preview
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent data, and evaluation of difficult to tr...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women’s Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
News Preview
BETHESDA, MD / ACCESS Newswire / September 11, 2025 / Lunai Bioworks Inc.'s (NASDAQ:RENB) wholly-owned subsidiary BioSymetrics Inc. today announced the award of a prestigious Small Business Technology Transfer (STTR) grant from the National Institutes of Health (NIH). The funding, awarded jointly to BioSymetrics and Brigham and Women's Hospital, wi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: LU2559000059
Moolec Science SA
MLEC
LISTED
NASDAQ
Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment
News Preview
WARWICK, GB / ACCESS Newswire / September 11, 2025 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC)("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced regulatory approval in...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: CH1335392721
Galderma Group AG
GALD
LISTED
XWSX
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
News Preview
Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking place in Paris, September 17-20, 2025. Highlighting its commitment to addressing skin conditions across the dermatology spectrum, Galderma will present...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.09.2025
ISIN: CH1429326825
Siegfried Holding AG
SFZN
LISTED
SIX
Siegfried successfully places senior bonds of CHF 300 million
News Preview
Siegfried AG
/ Key word(s): Bond
Siegfried successfully places senior bonds of CHF 300 million 11.09.2025 / 06:30 CET/CEST
Media Release
Zofingen, September 11, 2025
Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, today successfully placed bond......
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: DK0011048619
BioPorto A/S
BIOPOR
LISTED
CPH
US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker
News Preview
September 11, 2025News Release...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.09.2025
ISIN: CH1391448177
BeOne Medicines Ltd.
6160
LISTED
HKSE
BeOne Medicines Honored with the Global Oncology Innovation Leadership Award at BIOHK 2025, Supporting '1+' to Accelerate the Delivery of Innovative Cancer Therapies
News Preview
EQS Newswire / 11/09/2025 / 05:00 CET/CEST
HONG KONG SAR - Media OutReach Newswire - 11 September 2025 - BeOne Medicines (BeOne)(NASDAQ: ONC; HKEX: 06160; SSE: 688235), was honored today at BIOHK 2025, the Hong Kong International Biotechnology Conference & Exhibition, with the prestigious Global Oncology Innovation Leadership Award. This a......
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
News Preview
Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Invitation to Participate at DCNY Summit
News Preview
Hemogenyx Pharmaceuticals Invited to Participate at DCNY Summit LONDON, UK / ACCESS Newswire / September 11, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), is pleased to announce that the Company has been invited to participate and present at the upcoming DCNY Summit, taking place in Washington, DC on 18 September 2025 and in New York on 22 Septe...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Soleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
News Preview
Shares of Soleno Therapeutics, Inc. (“Soleno”) fell over 12% on September 10, 2025, after the company disclosed a patient death involving its treatment for Prader-Willi Syndrome, VYKAT XR. Previously, on Friday, August 15, 2025, Soleno stock dropped more than 8% after Scorpion Capital released a report alleging that VYKAT XR poses serious safety c...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US6047491013
Mirum Pharmaceuticals Inc
TKOMF
LISTED
OTC
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on September 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 10,820 shares of common stock and 5,390 restricted stock units (“RSUs”) to four new employees under Mirum’s 2020 Inducement P...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Financial Loss? Robbins LLP Informs Investors of the Lantheus Holdings, Inc. Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 10, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Lantheus Holdings, Inc. (NASAQ: LNTH) securities between February 26, 2025 and August 5, 2025. Lantheus is a global company that develops, manufactures, sells, and distribu...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s B...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Soleno Therapeutics, Inc. (“Soleno” or “the Company”) (NASDAQ: SLNO) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or faile...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclu...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates i...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Announces Launch of Secondary Offering of Common Stock
News Preview
LEHI, Utah and LOUISVILLE, Ky., Sept. 10, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced that certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively,...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US17331Y1091
Citius Oncology, Inc.
CTOR
LISTED
NASDAQ
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
News Preview
CRANFORD, N.J., Sept. 10, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced the closing of its p...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US4928541048
Kewaunee Scientific Corporation
KEQU
LISTED
NASDAQ
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026
News Preview
STATESVILLE, N.C., Sept. 10, 2025 /PRNewswire/ -- PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2025.
Fiscal Year 2026 First Quarter Results:
Sales during t...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced its collaboration with a leading breast cancer team from Yale Cancer Center for a clinical trial titled “A single arm phase II trial of circulating tumor DNA-guided adjuvant therapy with elacestrant in hormone receptor positive HER2 negative brea...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US42225T1079
Health Catalyst Inc
HCAT
LISTED
NASDAQ
Health Catalyst Appoints Ben Albert to the Role of President and COO
News Preview
Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement
SALT LAKE CITY, Sept. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert h...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US3847471014
Grail, Inc.
GRAL
LISTED
NASDAQ
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
News Preview
MENLO PARK, Calif., Sept. 10, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum on Wednesday, Sep. 24 at 8:00 a.m. ET. ...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Avidity Biosciences Announces Proposed Public Offering of Common Stock
News Preview
SAN DIEGO, Sept. 10, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that it intends to offer and sell, subject to market and other conditions, $500.0 million of shares of its common...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information to the investing public.
So What: If you purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: INE376G01013
Biocon Ltd
BIOCON
LISTED
Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
News Preview
CRANBURY, N.J. and BENGALURU, India, Sept. 10, 2025 /PRNewswire/ -- Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced the inauguration of its first U.S. manufacturing facility in Cranbury, New Jersey, by its wholly owned subsidiary, Biocon Generics Inc (BGI)....
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
News Preview
Cytek Biosciences will showcase its advanced, high-parameter cell analysis solutions at leading clinical global conferences ICCS and ESCCA....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
